Stay updated on Mirvetuximab Soravtansine Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.

Latest updates to the Mirvetuximab Soravtansine Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoved a government funding notice from the page. Core study details, inclusion criteria, and listed locations remain unchanged.SummaryDifference0.3%

- Check49 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT01609556 between the screenshots; the inclusion/exclusion criteria, study design, and listed locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedSignificant update: new operating-status notice and version 3.2.0, replacing v3.1.0; core content about current operations and where to check status has been added.SummaryDifference2%

- Check78 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page updates from Revision v3.0.1 to v3.0.2, indicating a new minor version. The 'Back to Top' link was removed; overall, no substantive changes to core content, pricing, or time-sensitive data.SummaryDifference0.1%

Stay in the know with updates to Mirvetuximab Soravtansine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.